Addressing implicit bias in pediatric hematology-oncology
Related Experiment Video
Updated: Dec 26, 2025

A Precision Medicine Tool for Measurement and Monitoring of Hemoglobin S in Sickle Cell Disease Patients Receiving Transfusion Therapy
Jessica W Tsai1,2, Jennifer C Kesselheim1,2
1Department of Pediatric Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts.
Abstract:
Although awareness of implicit bias and its influence on providers and patients is increasing, the effects of implicit bias on the field of pediatric hematology-oncology are less clear. This Special Report reviews the literature on implicit bias in pediatrics and medical oncology and further provides case examples and suggestions on what can be done to address implicit bias. There is a need for further research on how implicit bias impacts the complex care of pediatric hematology-oncology patients.
Related Concept Videos
Bias in Epidemiological Studies
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Drug Distribution
Halo Effect
Strategies for Assessing and Addressing Confounding
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

